Catalyst Event
Biogen Inc (BIIB) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
6/4/2026, 12:00:00 AM
Biogen's next-generation spinal muscular atrophy (SMA) therapy, salanersen, received Breakthrough Therapy Designation from the U.S. FDA on 2026-06-04; a medium impact is estimated due to accelerated market entry, expected.
Korean Translation
바이오젠의 차세대 척수성 근위축증(SMA) 치료제 살라너센(salanersen)이 2026년 6월 4일 미국 FDA로부터 획기적 치료제(Breakthrough Therapy Designation)로 지정받았으며, 개발 가속화에 따른 약 5% 이상의 주가 영향이 예상됨.
Related Recent Events
Synopsys Inc (SNPS) · Other
An investor day to discuss long-term financial targets and strategy is scheduled.
9/30/2026, 12:00:00 AM
Broadcom Inc (AVGO) · Earnings Release
Broadcom's Q3 2026 earnings release on September 3, 2026. This event is expected to have a medium impact as it will provide critical updates on AI revenue growth, scheduled
9/3/2026, 12:00:00 AM
NetApp Inc (NTAP) · Earnings Release
Next quarterly earnings for Q1 fiscal year 2027 are scheduled.
8/26/2026, 12:00:00 AM
HEICO Corp (HEI) · Earnings Release
Next quarterly earnings for Q3 2026 are scheduled to be reported on 2026-08-24, with analysts forecasting an EPS of $1.46; low importance is estimated as market impact is typically limited for scheduled announcements, scheduled.
8/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart is scheduled to release its Q2 FY2027 earnings results on 2026-08-20, scheduled. Medium importance is estimated as earnings releases typically trigger significant market volatility.
8/20/2026, 12:00:00 AM
Microsoft Corp (MSFT) · Other
Microsoft declared a quarterly dividend of $0.91 per share with an ex-dividend date of August 20, 2026, scheduled.
8/20/2026, 12:00:00 AM